Dosing Study of Radiation Combined With Tislelizumab and Pamiparib in Patients With Previously Treated Head and Neck Cancer
University of Chicago
University of Chicago
Arcus Biosciences, Inc.
AstraZeneca
Pfizer
DEKA Biosciences
Taiho Pharmaceutical Co., Ltd.
University of Chicago
Merck Sharp & Dohme LLC
University of California, San Francisco
Ruijin Hospital
Orient Europharma Co., Ltd.
AstraZeneca
Gustave Roussy, Cancer Campus, Grand Paris
Genentech, Inc.
Massachusetts General Hospital
Valerio Therapeutics
Merck KGaA, Darmstadt, Germany
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Galectin Therapeutics Inc.